Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $19.00 to $18.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 1.29% from the company’s current price.
A number of other research analysts have also weighed in on CCAP. Raymond James increased their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a research note on Friday, May 10th. Keefe, Bruyette & Woods increased their price target on Crescent Capital BDC from $18.50 to $19.00 and gave the stock an “outperform” rating in a research note on Thursday, May 23rd.
Get Our Latest Analysis on CCAP
Crescent Capital BDC Price Performance
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last announced its earnings results on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. The firm had revenue of $48.95 million for the quarter, compared to analysts’ expectations of $48.05 million. Crescent Capital BDC had a return on equity of 11.99% and a net margin of 53.32%. During the same quarter in the prior year, the firm earned $0.56 EPS. On average, analysts forecast that Crescent Capital BDC will post 2.34 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in CCAP. Cape Investment Advisory Inc. purchased a new position in shares of Crescent Capital BDC in the 4th quarter worth $63,000. Tucker Asset Management LLC purchased a new position in Crescent Capital BDC in the fourth quarter valued at about $167,000. XTX Topco Ltd purchased a new position in Crescent Capital BDC in the second quarter valued at about $195,000. Alpine Global Management LLC acquired a new stake in shares of Crescent Capital BDC during the first quarter valued at about $217,000. Finally, Catalina Capital Group LLC acquired a new stake in shares of Crescent Capital BDC during the second quarter valued at about $220,000. 49.46% of the stock is owned by hedge funds and other institutional investors.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Further Reading
- Five stocks we like better than Crescent Capital BDC
- What Are Dividend Champions? How to Invest in the Champions
- Chipotle Mexican Grill: Take a Bite of This Smoking Hot Deal
- About the Markup Calculator
- Why O’Reilly Automotive Stock Could Be a Long-Term Winner
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Hut 8 Corp.’s Earnings: Is Crypto Mining About to Change?
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.